Close Menu

NEW YORK (GenomeWeb) ­– Danaher announced Friday that it has completed its $4 billion acquisition of Cepheid.

Cepheid has been merged into Copper Merger Sub, a wholly owned subsidiary of Danaher, resulting in Cepheid becoming an indirect wholly owned subsidiary of Danaher.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.